StockData
Shattuck Labs, Inc. logo

Shattuck Labs, Inc. (STTK) stock

STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30
$4.59−0.07 (-1.50%)

Close on Nov 17, 2026Market cap $460.67MP/E –Yield –

Shattuck Labs operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Shattuck Labs's operating income for the twelve months ending Jun 30, 2026 was -$55.79M. For fiscal 2025 it was -$51.51M. The highest annual figure on record is -$25.07M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$51.51M–
FY2024Dec 31, 2024-$80.57M–
FY2023Dec 31, 2023-$91.96M–
FY2022Dec 31, 2022-$103.33M–
FY2021Dec 31, 2021-$45.27M–
FY2020Dec 31, 2020-$36.93M–
FY2019Dec 31, 2019-$25.07M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$16.16M–
Q1 FY2026Mar 31, 2026-$15.55M–
Q4 FY2025Dec 31, 2025-$13.37M–
Q3 FY2025Sep 30, 2025-$10.72M–
Q2 FY2025Jun 30, 2025-$13.03M–
Q1 FY2025Mar 31, 2025-$14.39M–
Q4 FY2024Dec 31, 2024-$19.64M–
Q3 FY2024Sep 30, 2024-$17.92M–
Q2 FY2024Jun 30, 2024-$22.96M–
Q1 FY2024Mar 31, 2024-$20.04M–
Q4 FY2023Dec 31, 2023-$18.95M–
Q3 FY2023Sep 30, 2023-$28.60M–
Q2 FY2023Jun 30, 2023-$22.75M–
Q1 FY2023Mar 31, 2023-$21.66M–
Q4 FY2022Dec 31, 2022-$26.28M-384.2%
Q3 FY2022Sep 30, 2022-$25.23M–
Q2 FY2022Jun 30, 2022-$27.66M–
Q1 FY2022Mar 31, 2022-$24.17M–
Q4 FY2021Dec 31, 2021$9.25M–
Q3 FY2021Sep 30, 2021-$17.58M–
Q2 FY2021Jun 30, 2021-$24.51M–
Q1 FY2021Mar 31, 2021-$12.42M–
Q4 FY2020Dec 31, 2020-$12.01M–
Q3 FY2020Sep 30, 2020-$11.84M–
Q2 FY2020Jun 30, 2020-$6.32M–
Q1 FY2020Mar 31, 2020-$6.76M–
Q4 FY2019Dec 31, 2019-$7.62M–
Q3 FY2019Sep 30, 2019-$7.53M–

More Shattuck Labs figures

See a number that looks wrong?